Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sartar Therapeutics logo — Developing treatment for soft tissue sarcomas

Sartar Therapeutics

Developing treatment for soft tissue sarcomas

Founded 2016 Finland Finland 4 employees

General Information

Company Name Sartar Therapeutics
Founded Year 2016
Location Finland Finland +1
Employees 4
Social

Get notified when Sartar Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Sartar Therapeutics

Sartar Therapeutics develops treatment for soft tissue sarcomas. The focus of cancer therapy is moving towards personalised medicine. There is a clear unmet need to find new therapies for the broad and heterogeneous group of soft tissue sarcomas. We are committed to delivering innovative, therapeutic options for the patients who currently have no specific therapies and for those who have run out of all currently available options.

No funding data available for Sartar Therapeutics yet.

Get notified when Sartar Therapeutics raises funding

Sartar Therapeutics Alternatives & Competitors

Sartar Therapeutics vs
CytRx
CytRx

Driving Oncology Innovation with Advanced Chemotherapeutic Solutions

Post Ipo Equity
Biopharma, Biotechnology
Sartar Therapeutics vs
FluidForm Bio
FluidForm Bio United States

FluidForm Bio™ is creating living human tissue for better treatment of disease. Our patented FRESH™...

Series Unknown
16 employees
Biopharma, Biotechnology
Sartar Therapeutics vs
DEKA Dental Lasers
DEKA Dental Lasers United States

DEKA Dental Lasers are the ultimate in soft tissue therapies and treatments in all areas of Dentistr...

5 employees
Health Care, Manufacturing

FAQ About Sartar Therapeutics

Developing treatment for soft tissue sarcomas
Sartar Therapeutics was founded in 2016.
Sartar Therapeutics is headquartered in Finland.
Sartar Therapeutics has approximately 4 employees.
Top alternatives and competitors to Sartar Therapeutics include CytRx, FluidForm Bio, DEKA Dental Lasers, Active Recovery Boston, Medical Massage of the Rockies, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sartar Therapeutics and CytRx are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Sartar Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy